Osteotech, Inc. (Nasdaq: OSTE) received a Nasdaq Staff Deficiency Letter in response to its notification to Nasdaq that Robert W ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE